Start with the product, its claims and each company’s role—not the size of the shipment.
The short answer
Possibly. FDA import-entry information, cosmetic facility registration and cosmetic product listing are different requirements. A small shipment or a small importing business does not automatically remove them. First establish whether the moisturizer is a cosmetic, a drug, or both. Then identify the manufacturer, importer and responsible person and test the rules that apply to each. [1–3]
Why it is more complicated than it sounds
A product intended only to moisturize or improve appearance will generally be evaluated as a cosmetic. Claims to treat acne or eczema, prevent disease, or affect the body’s structure or function can establish drug intended use. A moisturizer with sunscreen claims may be both a cosmetic and an over-the-counter drug. Packaging, websites, advertisements and other evidence of intended use matter. Calling it “skincare” or removing a claim from the invoice does not settle the question. [1]
If the product is a drug, separate drug requirements must be evaluated, including the applicable approval or OTC framework, establishment registration, listing and labeling. Cosmetic registration is not a substitute. Korean manufacture or sale overseas does not itself establish U.S. compliance. [1,4]
Facts that control the answer
Intended use and every U.S. marketing claim, including SPF, acne and treatment claims.
Complete ingredients, color additives, concentrations where relevant and applicable ingredient restrictions.
The facilities that manufacture or process the finished cosmetic and the legal entities performing each role.
Whose name appears on the label as manufacturer, packer or distributor—the MoCRA “responsible person” analysis is not simply “who imports.”
Whether a statutory small-business exemption actually applies to the relevant person or facility and product. [2–4]
Entry data is not MoCRA registration
The customs entry may need FDA product and shipment data, such as manufacturer, importer and product information, and applicable affirmation-of-compliance information. Those entry details do not replace MoCRA obligations. Non-exempt cosmetic facilities must register and renew biennially; a foreign facility must identify a U.S. agent. A non-exempt responsible person must list marketed cosmetic products, including ingredients, and update listing annually. FDA registration or listing does not mean FDA approved the moisturizer, and FDA does not issue a cosmetic registration “approval certificate.” [2,3]
Small-business exemptions have limits
MoCRA’s statutory small-business test uses average gross annual U.S. sales of cosmetic products over the preceding three years, with a $1 million threshold adjusted for inflation. It is not simply the importer’s employee count or this shipment’s value. The exemption from specified GMP and registration/listing provisions has product exclusions, including certain products contacting the eye’s mucous membrane, injected products, products intended for internal use, and products intended to alter appearance for more than 24 hours where consumer removal is not customary. A qualifying exemption does not eliminate every other cosmetic obligation, such as applicable safety, labeling and adverse-event requirements. It also does not create an exemption from drug requirements. Document the basis; do not rely on a supplier’s “small business” assurance. [2,5]
Questions to ask and documents to collect
Ask the supplier who manufactures and processes the product, who holds the formula, who appears on the U.S. label and who maintains safety and adverse-event records. Obtain the full ingredient list and relevant percentages; label artwork for every panel; translations; website and advertising claims; manufacturing locations; safety support; registration/listing details or a reasoned exemption basis; and the commercial invoice and packing list. Confirm who will provide the entry data and resolve FDA questions. A brand owner, factory and importer may have different obligations.
Common mistakes
Do not treat “cosmetic,” “FDA registered,” “natural” or “small batch” as a complete compliance analysis. Do not assume a U.S. agent is the same as the responsible person. Do not accept a supplier certificate as FDA approval. Do not finalize the commercial launch before checking whether the claims create a drug issue.
What importers should do now
Build one product file before ordering. Have the intended use, formula and U.S. labeling reviewed by an appropriate regulatory professional. Confirm each party’s responsibilities in writing and provide the licensed broker with consistent product and entry information. Portoria can help organize the readiness questions and commercial handoffs. Product-specific regulatory advice and customs brokerage require the appropriate separate professional engagement.
Primary sources
FDA: Registration & Listing of Cosmetic Product Facilities and Products ↗
FDA: Importing Cosmetics—entry information; use current MoCRA guidance for registration ↗
Educational information only. This is not legal advice, a binding classification decision, a customs ruling, or a guarantee of admissibility, eligibility or refunds. Requirements depend on the product, transaction and current law.
U.S. customs brokerage is offered separately by Luis F. Vinals, individually licensed U.S. Customs Broker, License No. 42975, under a separate engagement and CBP power of attorney. Portoria Solutions LLC is not a licensed customs broker and does not transact U.S. customs business.
Bring the question. Start with the facts.
Request a scoped readiness or planning discussion. Product-specific customs business requires the appropriate separate licensed professional engagement.
Request a Quote ↗Book a Consultation ↗
Written by Luis F. Vinals with the assistance of AI. Editorial & AI policy.
